ILMN

ILLUMINA INC

Healthcare • USA

Apr 05 • 04:00PM ET
83.62
2.72 (3.36%)

Company Description

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenat... read more

State

CA

Name ILLUMINA INC
Sector Healthcare
Currency USD
FULL TEST - ASSETS 6014000000.0
Market Cap 11746
Company Profile

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenat... read more

Full Time Employees 10,590
Phone 858 202 4500
Website https://www.illumina.com
CEO Mr. Jacob Thaysen Ph.D.
IPO Date 2000-07-28
Sector Healthcare
Address 5200 Illumina Way, San Diego, CA 92122